Fig. 7From: Mitochondrial targeted antioxidants, mitoquinone and SKQ1, not vitamin C, mitigate doxorubicin-induced damage in H9c2 myoblast: pretreatment vs. co-treatmentThe effects of Dox on intracellular ROS (A) and mitochondrial SO (B) levels. Dox showed dose-dependent increase in intracellular ROS and mitochondrial SO levels. **P < 0.01 vs the non-treated controlBack to article page